UK BIOBANK LIMITED

Trosolwg o'r elusen
Gweithgareddau - sut mae'r elusen yn gwario ei harian
To provide a major genetic resource to assist scientists with research into a variety of diseases and illnesses.
Incwm a gwariant
Data ar gyfer y flwyddyn ariannol yn gorffen 30 September 2023
Cyfanswm incwm:
£34,535,326
Roddion a chymynroddion | £9.14m | |
Weithgareddau elusennol | £24.81m | |
Weithgareddau masnachu eraill | £0 | |
Buddsoddiadau | £444.36k | |
Arall | £135.22k |
Cyfanswm gwariant:
£32,137,047
Codi arian | £0 | |
Weithgareddau elusennol | £32.14m | |
Arall | £0 |
£0 enillion (colledion) buddsoddiadau
Mae cyfanswm yr incwm yn cynnwys £13,384,924 o 10 grant(iau) llywodraeth
Gwariant elusennol
Gwariant elusennol gydag enillion buddsoddi
Charitable expenditure
Some charities generate all, or a substantial part, of their income from investments which may have been donated to the charity as endowment or set aside by the charity from its own resources in the past. Such investments usually take the form of stocks and shares but may include other assets, such as property, that are capable of generating income and/or capital growth.
In managing their spending and investments charities need to strike a balance between the needs of future and current beneficiaries. They also need to take account of spending commitments that may stretch over a number of future years. To do this, charities will normally adopt an investment strategy designed to generate both income and capital growth. To maximise returns trustees may commit to investment strategies for several years.
Investments can experience large swings in value so trustees may, in a particular year, decide to realise and spend part of their charity’s capital or to invest part of its income.
By clicking the investment gains checkbox the charitable spending bar is adjusted to take account of capital growth as well as income. This shows the balance the charity is striking, between spending on current beneficiaries and retaining resources for future beneficiaries.
Codi arian a Arall Gwariant | £0 | |
Gwariant elusennol | £32.14m | |
Cadwyd i'w ddefnyddio yn y dyfodol | £2.40m |
Pobl

228 Gweithwyr
12 Ymddiriedolwyr
Gweithwyr sydd â chyfanswm buddion dros £60,000
Nifer y cyflogeion | |
---|---|
£60k i £70k | 13 |
£70k i £80k | 4 |
£80k i £90k | 3 |
£90k i £100k | 2 |
£110k i £120k | 1 |
£150k i £200k | 5 |
Codi arian
Masnachu
Taliadau i ymddiriedolwyr
Beth, pwy, sut, ble
- Hybu Iechyd Neu’r Achub O Fywydau
- Y Cyhoedd/dynolryw
- Noddi Neu’n Gwneud Gwaith Ymchwil
- Gweithredu Fel Corff Mantell Neu Gorff Adnoddau
- Cymru A Lloegr
- Yr Alban
Llywodraethu
- 30 Rhagfyr 2003: Cofrestrwyd
Dim enwau eraill
- Polisi a gweithdrefnau bwlio ac aflonyddu
- Trin cwynion
- Polisi a gweithdrefnau cwynion
- Buddiannau croes
- Polisi a gweithdrefnau cronfeydd arian wrth gefn
- Polisi a gweithdrefnau rheolaethau ariannol mewnol elusen
- Polisi a gweithdrefnau rheoli risg mewnol
- Polisi a gweithdrefnau buddsoddi cronfeydd elusen
- Buddsoddi
- Talu staff
- Rheoli risg
- Polisi a gweithdrefnau diogelu
- Polisi a gweithdrefnau adrodd am ddigwyddiadau difrifol
- Polisi a gweithdrefnau cyfryngau cymdeithasol
- Polisi a gweithdrefnau gwrthdaro buddiannau ymddiriedolwyr
- Polisi a gweithdrefnau treuliau ymddiriedolwyr
Ymddiriedolwyr
Ymddiriedolwyr yw’r bobl sy’n gyfrifol am reoli’ gwaith, rheolaeth a gweinyddiaeth yr elusen. Gellir adnabod ymddiriedolwyr wrth enwau eraill megis cyfarwyddwyr, aelodau pwyllgor, llywodraethwyr neu rywbeth arall, ac nid ydynt fel arfer wedi’u cyflogi gan yr elusen. Mae’r ymddiriedolwyr yn gyfrifol am ddiweddaru'r rhestr hon a gallant wneud hyn wrth ddiweddaru eu manylion fel y maent yn digwydd trwy'r gwasanaeth ar-lein.
12 Ymddiriedolwyr
Enw | Rôl | Dyddiad y penodiad | Ymddiriedolaethau eraill | Statws adrodd ymddiriedolaethau eraill | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lord Ajay Kumar Kakkar | Cadeirydd | 01 January 2020 |
|
|||||||||||
Professor Melinda Catherine Mills | Ymddiriedolwr | 01 June 2024 |
|
|||||||||||
Dr Claire Fiona Newland | Ymddiriedolwr | 01 May 2024 |
|
|
||||||||||
Dame Professor Clare Gerada | Ymddiriedolwr | 19 January 2024 |
|
|
||||||||||
Bernard Taylor | Ymddiriedolwr | 19 January 2024 |
|
|
||||||||||
Professor Sir Michael Ferguson | Ymddiriedolwr | 01 June 2022 |
|
|
||||||||||
Nicola Perrin | Ymddiriedolwr | 01 June 2022 |
|
|
||||||||||
Dominic Dodd | Ymddiriedolwr | 17 September 2021 |
|
|||||||||||
Tariq Khokhar | Ymddiriedolwr | 17 September 2021 |
|
|||||||||||
Professor Dame Nancy Jane Rothwell | Ymddiriedolwr | 17 September 2021 |
|
|
||||||||||
PROFESSOR ANNEKE LUCASSEN | Ymddiriedolwr | 01 August 2018 |
|
|
||||||||||
PROFESSOR SIR ALEX MARKHAM | Ymddiriedolwr | 24 March 2017 |
|
Hanes ariannol
Dyddiad diwedd cyfnod ariannol
Incwm / Gwariant | 30/09/2019 | 30/09/2020 | 30/09/2021 | 30/09/2022 | 30/09/2023 | ||
---|---|---|---|---|---|---|---|
|
Cyfanswm Incwm Gros | £44.72m | £35.19m | £62.73m | £40.64m | £34.54m | |
|
Cyfanswm gwariant | £42.51m | £39.17m | £63.62m | £38.93m | £32.14m | |
|
Incwm o gontractau'r llywodraeth | N/A | N/A | N/A | N/A | N/A | |
|
Incwm o grantiau'r llywodraeth | N/A | N/A | £325.36k | N/A | £13.38m | |
|
Incwm o roddion a chymynroddion | £37.49m | £21.48m | £6.62m | £902.48k | £9.14m | |
|
Incwm o weithgareddau masnachu eraill | £4.04m | £3.77m | £10.12m | £7.84m | £0 | |
|
Incwm - Weithgareddau elusennol | £2.23m | £2.21m | £2.59m | £2.03m | £24.81m | |
|
Incwm - Gwaddolion | £0 | £0 | £0 | £0 | £0 | |
|
Incwm - Buddsoddiad | £81.97k | £59.80k | £4.79k | £93.31k | £444.36k | |
|
Incwm - Arall | £873.84k | £7.68m | £43.39m | £29.77m | £135.22k | |
|
Incwm - Cymynroddion | £0 | £0 | £0 | £0 | £0 | |
|
Gwariant - Ggweithgareddau elusennol | £37.68m | £28.26m | £31.98m | £24.16m | £32.14m | |
|
Gwariant - Ar godi arian | £0 | £0 | £0 | £0 | £0 | |
|
Gwariant - Llywodraethu | £97.50k | £73.31k | £85.59k | £48.04k | £60.08k | |
|
Gwariant - Sefydliad grantiau | £0 | £0 | £0 | £0 | £0 | |
|
Gwariant - Rheoli buddsoddiadau | £0 | £0 | £0 | £0 | £0 | |
|
Gwariant - Arall | £4.82m | £10.92m | £31.64m | £14.76m | £0 |
Asedau a rhwymedigaethau
Diffiniadau ar gyfer asedau a rhwymedigaethau
Asedau yw’r rhain, ac nid buddsoddiadau, a ddelir am fwy na 12 mis ac a ddefnyddir i redeg a gweinyddu’r elusen megis adeiladau, swyddfeydd, arddangosfeydd a gosodiadau a ffitiadau.
Buddsoddiadau Tymor HirBuddsoddiadau yw asedau a ddelir gan yr elusen gyda’r unig nod o gynhyrchu incwm a ddefnyddir ar gyfer eu dibenion elusennol megis cyfrifon cadw, rhanddaliadau, eiddo a rentir ac ymddiriedolaethau unedau.
Ailbrisir asedau buddsoddi bob blwyddyn ac fe’u cynhwysir yn y fantolen ar eu gwerth marchnad cyfredol.
Delir buddsoddiadau tymor hir am fwy na 12 mis.
Asedau yw’r rhain a ddelir yn gyffredinol am lai na 12 mis megis arian parod a balansau banc, dyledwyr, buddsoddiadau i'w gwerthu o fewn y flwyddyn sydd i ddod a stoc masnachu.
Ased neu rwymedigaeth cynllun pensiwn budd a ddiffiniwydArian dros ben neu ddiffyg yw hwn mewn unrhyw gynllun pensiwn budd a ddiffinnir sy’n cael ei weithredu ac mae’n cynrychioli ased neu rwymedigaeth tymor hir botensial.
Cyfanswm rhwymedigaethauDyma’r holl symiau sy’n ddyledus gan yr elusen ar ddyddiad y daflen balans i drydydd partïon megis biliau sy’n ddyledus ond heb eu talu hyd yn hyn, gorddrafftiau banc a benthyciadau a morgeisi.
Asset / Liability | 30/09/2019 | 30/09/2020 | 30/09/2021 | 30/09/2022 | 30/09/2023 | ||
---|---|---|---|---|---|---|---|
|
Asedau hunan ddefnydd | £11.94m | £10.62m | £7.69m | £6.76m | £7.08m | |
|
Buddsoddiadau tymor hir | £0 | £0 | £0 | £0 | £0 | |
|
Cyfanswm asedau | £18.47m | £23.17m | £27.24m | £34.51m | £31.08m | |
|
Ased neu rwymedigaeth cynllun pensiwn budd a ddiffiniwyd | -£1.68m | -£1.77m | -£6.23m | -£5.97m | -£8.04m | |
|
Cyfanswm rhwymedigaethau | £12.39m | £19.67m | £17.23m | £22.14m | £27.24m |
Cyfrifon a datganiadau enillion blynyddol
Teitl | Blwyddyn adrodd | Dyddiad derbyn | Derbyniwyd | Download |
---|---|---|---|---|
Adroddiad blynyddol | 30 Medi 2023 | 26 Gorffennaf 2024 | Ar amser | |
Cyfrifon a TAR | 30 Medi 2023 | 26 Gorffennaf 2024 | Ar amser | Download Agorwch mewn ffenestr newydd |
Adroddiad blynyddol | 30 Medi 2022 | 25 Gorffennaf 2023 | Ar amser | |
Cyfrifon a TAR | 30 Medi 2022 | 25 Gorffennaf 2023 | Ar amser | Download Agorwch mewn ffenestr newydd |
Adroddiad blynyddol | 30 Medi 2021 | 01 Gorffennaf 2022 | Ar amser | |
Cyfrifon a TAR | 30 Medi 2021 | 01 Gorffennaf 2022 | Ar amser | Download Agorwch mewn ffenestr newydd |
Adroddiad blynyddol | 30 Medi 2020 | 15 Gorffennaf 2021 | Ar amser | |
Cyfrifon a TAR | 30 Medi 2020 | 15 Gorffennaf 2021 | Ar amser | Download Agorwch mewn ffenestr newydd |
Adroddiad blynyddol | 30 Medi 2019 | 30 Gorffennaf 2020 | Ar amser | |
Cyfrifon a TAR | 30 Medi 2019 | 30 Gorffennaf 2020 | Ar amser | Download Agorwch mewn ffenestr newydd |
Dogfen lywodraethu
Nid dyma destun llawn dogfen lywodraethu'r elusen.
MEMORANDUM AND ARTICLES INCORPORATED 28/11/2003 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 17/12/2007 AS AMENDED BY SPECIAL RESOLUTION(S) DATED 28/10/2015
Gwrthrychau elusennol
THE OBJECTS FOR WHICH THE COMPANY IS ESTABLISHED ARE TO PROTECT, PRESERVE AND ADVANCE ALL OR ANY ASPECTS OF THE HEALTH AND WELFARE OF HUMAN BEINGS AND TO ADVANCE AND PROMOTE KNOWLEDGE AND EDUCATION BY ENGAGING IN, ENCOURAGING AND SUPPORTING: 1) INVESTIGATIONS INTO THE SEPARATE AND COMBINED EFFECTS OF GENETIC, ENVIRONMENTAL (INCLUDING LIFESTYLE, PHYSIOLOGICAL AND ENVIRONMENTAL EXPOSURES) AND OTHER FACTORS ON HUMAN HEALTH AND WELFARE AND ON THE RISK AND CAUSATION OF DISEASES IN THE HUMAN POPULATION; (2) THE ESTABLISHMENT, HOLDING, OPERATION, MANAGEMENT, PROMOTION, SUPPORT, EXPANSION, IMPROVEMENT AND SAFEGUARDING OF A COLLECTION OF BIOMEDICAL, BIOCHEMICAL, EPIDEMIOLOGICAL, GENETIC AND OTHER DATA AND BLOOD AND OTHER BIOLOGICAL AND BIOCHEMICAL SAMPLES OBTAINED AND DEVELOPED THROUGH, FOR THE PURPOSE OF AND/OR IN CONNECTION WITH SOME OR ALL OF THE INVESTIGATIONS REFERRED TO IN PARAGRAPH (1) AND PERTAINING TO A COHORT OF HUMAN PARTICIPANTS ("DATA AND SAMPLES"), FOR USE IN A RESEARCH, KNOWLEDGE AND INFORMATION RESOURCE PROVISIONALLY KNOWN AS THE UK BIOBANK ("THE RESOURCE"); (3) RESEARCH INTO BIOLOGICAL AND MEDICAL SCIENCES AND OTHER DISCIPLINES WHICH MAY CONTRIBUTE TO THE IMPROVEMENT OF HUMAN HEALTH AND WELFARE ("THE BIOSCIENCES"); (4) THE DISCOVERY, INVENTION, IMPROVEMENT, DEVELOPMENT AND APPLICATION OF TREATMENTS, CURES, DIAGNOSTICS AND OTHER MEDICINAL AGENTS, METHODS AND PROCESSES THAT MAY IN ANY WAY RELIEVE ILLNESS, DISEASE, DISABILITY OR DISORDERS OF WHATEVER NATURE IN HUMAN BEINGS; AND (5) THE STUDY AND UNDERSTANDING OF ANY OF THE BIOSCIENCES.
Maes buddion
NATIONAL
Contact Information
- Cyfeiriad yr elusen:
-
UK Biobank Ltd
Unit 1-2
Spectrum Way
Stockport
SK3 0SA
- Ffôn:
- 01614755360
- E-bost:
- enquiries@ukbiobank.ac.uk
Tell us whether you accept cookies
We use cookies to collect information about how you use your Charity Commission Account, such as pages you visit.
We use this information to better understand how you use our website so that we can improve your user experience and present more relevant content.
Diolch am eich adborth. Oes gennych 5 munud i rannu eich barn am y gwasanaeth hwn?Open in new window